Evidence map›Paper›PMID 25249551›Full record

ArticleJournal of the National Cancer Institute2014

An action plan for translating cancer survivorship research into care.

Catherine M Alfano, Tenbroeck Smith, Janet S de Moor, Russell E Glasgow, Muin J Khoury, Nikki A Hawkins, Kevin D Stein, Ruth Rechis, Carla Parry, Corinne R Leach and 2 more

Abstract readConference Proceedings
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of the National Cancer Institute, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
29.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 74 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Review
  5. Article
  6. Article
  7. Defining research and infrastructure priorities for cancer survivorship in Australia: a modified Delphi study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Article
  8. Article
  9. Research contributions from the First Cancer Center Survivorship Research Forum.Journal of cancer survivorship : research and practice · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Survivorship and Caregiver Issues in Neuro-oncology.Current treatment options in oncology · 2019
    Review
  17. The Integration of Survivorship Care Planning at a Comprehensive Cancer Center.Journal of the advanced practitioner in oncology · 2019
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Catherine M AlfanoBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP). catherine.alfano@nih.gov.
Tenbroeck SmithBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Janet S de MoorBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Russell E GlasgowBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Muin J KhouryBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Nikki A HawkinsBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Kevin D SteinBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Ruth RechisBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Carla ParryBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Corinne R LeachBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Lynne PadgettBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Julia H RowlandBehavioral Research Program (CMA, CP, LP), Applied Research Program (JSdM), Implementation Science Team (REG), Epidemiology and Genomics Research Program (MJK), and Office of Cancer Survivorship (JHR), Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD; Behavioral Research Center, American Cancer Society, Atlanta, GA (TS, KDS, CRL); Office of Public Health Genomics (MJK) and Division of Cancer Prevention and Control (NAH), Centers for Disease Control and Prevention, Atlanta, GA; LIVESTRONG Foundation, Austin, TX (RR); Present addresses: Department of Family Medicine, University of Colorado, Denver, CO (REG); Department of Research and Evaluation, Kaiser Permanente Research, Pasadena, CA (CP).
Centers for Disease Control and Prevention · USNational Cancer Institute · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To meet the complex needs of a growing number of cancer survivors, it is essential to accelerate the translation of survivorship research into evidence-based interventions and, as appropriate, recommendations for care that may be implemented in a wide variety of settings. Current progress in translating research into care is stymied, with results of many studies un- or underutilized. To better understand this problem and identify strategies to encourage the translation of survivorship research findings into practice, four agencies (American Cancer Society, Centers for Disease Control and Prevention, LIVE STRONG: Foundation, National Cancer Institute) hosted a meeting in June, 2012, titled: "Biennial Cancer Survivorship Research Conference: Translating Science to Care." Meeting participants concluded that accelerating science into care will require a coordinated, collaborative effort by individuals from diverse settings, including researchers and clinicians, survivors and families, public health professionals, and policy makers. This commentary describes an approach stemming from that meeting to facilitate translating research into care by changing the process of conducting research-improving communication, collaboration, evaluation, and feedback through true and ongoing partnerships. We apply the T0-T4 translational process model to survivorship research and provide illustrations of its use. The resultant framework is intended to orient stakeholders to the role of their work in the translational process and facilitate the transdisciplinary collaboration needed to translate basic discoveries into best practices regarding clinical care, self-care/management, and community programs for cancer survivors. Finally, we discuss barriers to implementing translational survivorship science identified at the meeting, along with future directions to accelerate this process.

Indexed as

Interdisciplinary CommunicationQuality of Health CareSurvivorsTranslational Research, BiomedicalCooperative BehaviorHealth Services Needs and DemandHumansNeoplasmsSurvival RateUnited States

Identifiers

PMID25249551
PMCPMC4184343
OpenAlexW2004870696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.